Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus.
Viruses can induce progressive neurologic disorders associated with diverse pathological manifestations, and therefore, viral infection of the brain can impair differentiated neural functions, depending on the initial viral tropism. We have previously reported that canine distemper virus (CDV) targets certain mouse brain structures, including the hypothalamus, early and selectively. Infected mice exhibit acute encephalitis, with late disease, characterized by motor impairment or obesity syndrome, appearing in some of the surviving mice several months after the initial viral replication. In the present study, we show viral persistence in the hypothalami of obese mice, as demonstrated by low, but still significant, levels of CDV nucleoprotein transcripts, associated with a dramatic decrease in F gene mRNAs. Given the pivotal role of the hypothalamus in obesity (eating behavior, energy consumption, and neuroendocrine function) and that of leptin, the adipose tissue-derived satiety factor acting through hypothalamic receptors, we analyzed the leptin networks in both obese and nonobese mice. The discrepancy found between the chronic and dramatic increase in blood leptin levels and the occurrence of obesity may be due to leptin resistance in the brain. In fact, expression of the long leptin receptor isoform, representing the functional leptin receptor, was specifically downregulated in the hypothalami of obese mice, explaining their inability to generate an adequate response to leptin in the brain. Intriguingly, during the acute phase of infection, its expression was increased in CDV-targeted structures in all infected mice and remained high in obese mice in all CDV-targeted structures, except for the hypothalamus. The biphasic change in hypothalamic leptin receptor expression seen during the progression of CDV-induced obesity provides a new paradigm for understanding mechanisms of neuroendocrinological, virus-induced abnormalities.
Bernard
A
A
INSERM U433, Neurobiologie Expérimentale et Physiopathologie, Faculté de Médecine RTH Laënnec, 69372 Lyon Cedex 08, France. abernard@lyon151.inserm.fr
Cohen
R
R
Khuth
S T
ST
Vedrine
B
B
Verlaeten
O
O
Akaoka
H
H
Giraudon
P
P
Belin
M F
MF
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002352:Carrier Proteins / Q000235:genetics; D002522:Chlorocebus aethiops; D004216:Distemper / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D004217:Distemper Virus, Canine / Q000502:physiology*; D004285:Dogs; D005260:Female; D015870:Gene Expression; D007031:Hypothalamus / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D020738:Leptin; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009767:Obesity, Morbid / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D011506:Proteins / Q000378:metabolism*; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D014709:Vero Cells; D014760:Viral Fusion Proteins / Q000096:biosynthesis / Q000235:genetics
D002352:Carrier Proteins; D007328:Insulin; D020738:Leptin; D011506:Proteins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D014760:Viral Fusion Proteins; C515447:leptin receptor, mouse; C076619:F protein, Phocine distemper virus